Frontiers in Nanotechnologies for Delivery of Small Molecules and Biologics

With more insoluble chemical entities emerging from the drug discovery pipeline comes the challenge of finding the appropriate technology for improving solubility and bioavailability. Ascendia’s enabling platform technologies can help overcome these challenges by designing better and smarter formulations for oral and parenteral drug molecules across all modalities. Ascendia’s expertise and cGMP capabilities in manufacturing of innovative and complex generics can help expedite the development process of oral and injectable drugs, and reduce time and cost.

Register Free: https://www.pharmtech.com/pt/nanotechnologies

Event Overview:

Key Learning Objectives:

• How to tackle poorly soluble molecules across all modalities
• What to know about polymeric nanoparticles (PNPs) and lipid nanoparticles (LNPs)
• cGMP manufacturing and capabilities of PNPs/LNPs

Who Should Attend:

• Formulation scientists working with poorly soluble small and large molecules
• Managers, vice presidents and chief scientific officers working with challenging molecules
• Students and professors interested in innovative approaches for improving the solubility and bioavailability of molecules

Speaker:

Shaukat Ali, PhD
Sr. Director Scientific Affairs and Technical Marketing
Ascendia Pharma

Dr Shaukat Ali joins Ascendia Pharmaceuticals Inc. as senior director of scientific affairs and technical marketing after having worked in the pharma and biotech industry for nearly 30 years. His areas of expertise include lipid chemistry; liposomes; surfactant-based drug delivery systems; SEDDS/SMEDDS; amorphous solid dispersions; oral, parenteral, topical and transdermal drug delivery; and immediate and controlled release formulations. He received his PhD in Organic Chemistry from the City University of New York and received postdoctoral training in Physical Biochemistry of lipids at the University of Minnesota and Cornell University.

Dr Ali has published over 60 articles in scientific journals and is an inventor/coinventor of several US and European patents. He is the recipient of IPEC’s Henk de Jong Industrial Research Award. He has served as the USP council of experts for the General Chapters-Physical Analysis (2010-2020), and continues to serve as USP council of experts for the Excipient Test Methods committee (2020-2025). He is co-chair of the AAPS Lipid Focus Group.

Register Free: https://www.pharmtech.com/pt/nanotechnologies